|
It was reported to medtronic minimed that the customer reported high blood glucose and a loss of communication between the insulin pump and transmitter.The customer reported a blood glucose value of 600 mg/dl.The customer reported hyperglycemia was treated with the manual injection/insulin pen.The event involved products mmt-332a, mmt-7841zn, mmt-866a, and mmt-1884.Troubleshooting was performed for the communication issue, and the communication was resolved after deleting the transmitter serial number from the pump and re-pairing.Troubleshooting was partially performed for high blood glucose, and it was unknown whether the customer has been using the insulin pump system within 48 hours of the reported high blood glucose event or not.It was unknown whether the customer was used the auto mode feature at the time of the event or not.No further patient complications were reported.No product return is required for mmt-332a, mmt-7841zn, mmt-866a, and mmt-1884.
|
|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.No conclusion can be drawn at this time.We therefore consider this report complete to the best of our knowledge.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|